|
Originally published In Press as doi:10.1074/jbc.M203318200 on July 8, 2002
J. Biol. Chem., Vol. 277, Issue 41, 38503-38516, October 11, 2002
Identification of a Novel Family of Oxidized Phospholipids That
Serve as Ligands for the Macrophage Scavenger Receptor CD36*
Eugene A.
Podrez ,
Eugenia
Poliakov§,
Zhongzhou
Shen ¶,
Renliang
Zhang  **,
Yijun
Deng§,
Mingjiang
Sun§,
Paula J.
Finton ,
Lian
Shan ** ,
Bogdan
Gugiu§,
Paul
L.
Fox ,
Henry F.
Hoff  ,
Robert G.
Salomon§, and
Stanley L.
Hazen    §§
From the Department of Cell Biology and
Department of Cardiovascular Medicine, Cleveland Clinic
Foundation, Cleveland, Ohio 44195, the § Department of
Chemistry, Case Western Reserve University, Cleveland, Ohio 44106, the  Department of Chemistry, Cleveland
State University, Cleveland, Ohio 44115, and the Center for
Cardiovascular Diagnostics and Prevention, Preventive Cardiology
Section, Cleveland Clinic Foundation, Cleveland, Ohio 44195
The macrophage scavenger receptor CD36 plays an
important role in the uptake of oxidized forms of low density
lipoprotein (LDL) and contributes to lesion development in murine
models of atherosclerosis. However, the structural basis of CD36
lipoprotein ligand recognition is unknown. We now identify a novel
class of oxidized phospholipids that serve as high affinity ligands for CD36 and mediate recognition of oxidized forms of LDL by CD36 on
macrophages. Small unilamellar vesicles of homogeneous
phosphatidylcholine (PC) molecular species were oxidized by the
myeloperoxidase
(MPO)-H2O2-NO system, and products were separated by sequential LC/ESI/MS/MS. In parallel, fractions were tested for their ability to bind to CD36.
Four major structurally related phospholipids with CD36 binding
activity were identified from oxidized 1-palmitoyl-2-arachidonyl-PC, and four corresponding structural analogs with CD36 binding activity were identified from oxidized 1-palmitoyl-2-linoleoyl-PC. Each was then
synthetically prepared, its structure confirmed by multinuclear NMR and high resolution mass spectrometry, and shown to possess identical CD36 binding activity and LC/ESI/MS/MS characteristics in
both native and derivatized forms. Based upon the structures of the
active compounds identified, and structure-function studies with a
variety of synthetic analogs, we conclude that the structural characteristics required for high affinity binding of oxidized PC
species to CD36 are a phospholipid with an sn-2 acyl
group that incorporates a terminal -hydroxy(or
oxo)- , -unsaturated carbonyl (oxPCCD36). LC/ESI/MS/MS
studies demonstrate that oxPCCD36 are formed during LDL
oxidation by multiple distinct pathways. Formation of this novel class
of oxidized PC species contributes to CD36-mediated recognition of LDL
oxidized by MPO and other biologically relevant mechanisms. The present
results offer structural insights into the molecular patterns
recognized by the scavenger receptor CD36 and provide a platform for
the development of potential therapeutic inhibitory agents.
*
This work was supported in part by National Institutes of
Health Grants HL62526, HL70621, HL61878 (to S. L. H.), GM21249 (to R. G. S.), and HL53315 (to H. F. H. and R. G. S.), and a
Scientist Development grant from the American Heart Association (to
E. A. P.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Recipient of a Jane Coffin Childs Memorial Fund for Medical
Research Fellowship.
**
Supported American Heart Association fellowship.
§§
To whom correspondence should be addressed: Cleveland Clinic
Foundation, Lerner Research Institute, Dept. of Cell Biology, 9500 Euclid Ave., NC-10, Cleveland, OH 44195. Tel.: 216-445-9763; Fax:
216-444-9404; E-mail: hazens@ccf.org.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Harb, K. Bujold, M. Febbraio, M. G. Sirois, H. Ong, and S. Marleau
The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation
Cardiovasc Res,
July 1, 2009;
83(1):
42 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bujold, D. Rhainds, C. Jossart, M. Febbraio, S. Marleau, and H. Ong
CD36-mediated cholesterol efflux is associated with PPAR{gamma} activation via a MAPK-dependent COX-2 pathway in macrophages
Cardiovasc Res,
May 13, 2009;
(2009)
cvp118v2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Asai, F. Okajima, K. Nakagawa, D. Ibusuki, K. Tanimura, Y. Nakajima, M. Nagao, M. Sudo, T. Harada, T. Miyazawa, et al.
Phosphatidylcholine hydroperoxide-induced THP-1 cell adhesion to intracellular adhesion molecule-1
J. Lipid Res.,
May 1, 2009;
50(5):
957 - 965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. McIntyre, S. M. Prescott, and D. M. Stafforini
The emerging roles of PAF acetylhydrolase
J. Lipid Res.,
April 1, 2009;
50(Supplement):
S255 - S259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. von Schlieffen, O. V. Oskolkova, G. Schabbauer, F. Gruber, S. Bluml, M. Genest, A. Kadl, C. Marsik, S. Knapp, J. Chow, et al.
Multi-Hit Inhibition of Circulating and Cell-Associated Components of the Toll-Like Receptor 4 Pathway by Oxidized Phospholipids
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2009;
29(3):
356 - 362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chen, X. Chen, R. G. Salomon, and T. M. McIntyre
Platelet Activation by Low Concentrations of Intact Oxidized LDL Particles Involves the PAF Receptor
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2009;
29(3):
363 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. K. Mishra, M. N. Palgunachari, N. R. Krishna, J. Glushka, J. P. Segrest, and G. M. Anantharamaiah
Effect of Leucine to Phenylalanine Substitution on the Nonpolar Face of a Class A Amphipathic Helical Peptide on Its Interaction with Lipid: HIGH RESOLUTION SOLUTION NMR STUDIES OF 4F-DIMYRISTOYLPHOSPHATIDYLCHOLINE DISCOIDAL COMPLEX
J. Biol. Chem.,
December 5, 2008;
283(49):
34393 - 34402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-K. Jyrkkanen, E. Kansanen, M. Inkala, A. M. Kivela, H. Hurttila, S. E. Heinonen, G. Goldsteins, S. Jauhiainen, S. Tiainen, H. Makkonen, et al.
Nrf2 Regulates Antioxidant Gene Expression Evoked by Oxidized Phospholipids in Endothelial Cells and Murine Arteries In Vivo
Circ. Res.,
July 3, 2008;
103(1):
e1 - e9.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Chen, M. Febbraio, W. Li, and R. L. Silverstein
A Specific CD36-Dependent Signaling Pathway Is Required for Platelet Activation by Oxidized Low-Density Lipoprotein
Circ. Res.,
June 20, 2008;
102(12):
1512 - 1519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Hazen
Oxidized Phospholipids as Endogenous Pattern Recognition Ligands in Innate Immunity
J. Biol. Chem.,
June 6, 2008;
283(23):
15527 - 15531.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kim, A. T. Tolhurst, L. Y. Qin, X.-Y. Chen, M. Febbraio, and S. Cho
CD36/Fatty Acid Translocase, An Inflammatory Mediator, Is Involved in Hyperlipidemia-Induced Exacerbation in Ischemic Brain Injury
J. Neurosci.,
April 30, 2008;
28(18):
4661 - 4670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Z. Ashraf, N. S. Kar, X. Chen, J. Choi, R. G. Salomon, M. Febbraio, and E. A. Podrez
Specific Oxidized Phospholipids Inhibit Scavenger Receptor BI-mediated Selective Uptake of Cholesteryl Esters
J. Biol. Chem.,
April 18, 2008;
283(16):
10408 - 10414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Chen, W. Zhang, J. Laird, S. L. Hazen, and R. G. Salomon
Polyunsaturated phospholipids promote the oxidation and fragmentation of {gamma}-hydroxyalkenals: formation and reactions of oxidatively truncated ether phospholipids
J. Lipid Res.,
April 1, 2008;
49(4):
832 - 846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Kar, M. Z. Ashraf, M. Valiyaveettil, and E. A. Podrez
Mapping and Characterization of the Binding Site for Specific Oxidized Phospholipids and Oxidized Low Density Lipoprotein of Scavenger Receptor CD36
J. Biol. Chem.,
March 28, 2008;
283(13):
8765 - 8771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Davis, G. Koster, L. J. Douet, M. Scigelova, G. Woffendin, J. M. Ward, A. Smith, J. Humphries, K. G. Burnand, C. H. Macphee, et al.
Electrospray Ionization Mass Spectrometry Identifies Substrates and Products of Lipoprotein-associated Phospholipase A2 in Oxidized Human Low Density Lipoprotein
J. Biol. Chem.,
March 7, 2008;
283(10):
6428 - 6437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Greenberg, X.-M. Li, B. G. Gugiu, X. Gu, J. Qin, R. G. Salomon, and S. L. Hazen
The Lipid Whisker Model of the Structure of Oxidized Cell Membranes
J. Biol. Chem.,
January 25, 2008;
283(4):
2385 - 2396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Marsche, B. Weigle, W. Sattler, and E. Malle
Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein
FASEB J,
October 1, 2007;
21(12):
3075 - 3082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kanayama, S. Yamaguchi, T. Shibata, N. Shibata, M. Kobayashi, R. Nagai, H. Arai, K. Takahashi, and K. Uchida
Identification of a Serum Component That Regulates Cyclooxygenase-2 Gene Expression in Cooperation with 4-Hydroxy-2-nonenal
J. Biol. Chem.,
August 17, 2007;
282(33):
24166 - 24174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Collot-Teixeira, J. Martin, C. McDermott-Roe, R. Poston, and J. L. McGregor
CD36 and macrophages in atherosclerosis
Cardiovasc Res,
August 1, 2007;
75(3):
468 - 477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Gille, B. Spring, W. Bernhard, C. Gebhard, D. Basile, K. Lauber, C. F. Poets, and T. W. Orlikowsky
Differential effect of surfactant and its saturated phosphatidylcholines on human blood macrophages
J. Lipid Res.,
February 1, 2007;
48(2):
307 - 317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Knapp, U. Matt, N. Leitinger, and T. van der Poll
Oxidized Phospholipids Inhibit Phagocytosis and Impair Outcome in Gram-Negative Sepsis In Vivo
J. Immunol.,
January 15, 2007;
178(2):
993 - 1001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Greenberg, M. Sun, R. Zhang, M. Febbraio, R. Silverstein, and S. L. Hazen
Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells
J. Exp. Med.,
November 27, 2006;
203(12):
2613 - 2625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M McMahon, J Grossman, W Chen, and B H Hahn
Inflammation and the pathogenesis of atherosclerosis in systemic lupus erythematosus
Lupus,
November 1, 2006;
15(11_suppl):
59 - 69.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gao, R. Zhang, M. E. Greenberg, M. Sun, X. Chen, B. S. Levison, R. G. Salomon, and S. L. Hazen
Phospholipid Hydroxyalkenals, a Subset of Recently Discovered Endogenous CD36 Ligands, Spontaneously Generate Novel Furan-containing Phospholipids Lacking CD36 Binding Activity in Vivo
J. Biol. Chem.,
October 20, 2006;
281(42):
31298 - 31308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Mwaikambo, F. Sennlaub, H. Ong, S. Chemtob, and P. Hardy
Activation of CD36 Inhibits and Induces Regression of Inflammatory Corneal Neovascularization.
Invest. Ophthalmol. Vis. Sci.,
October 1, 2006;
47(10):
4356 - 4364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Watson
Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Lipidomics: a global approach to lipid analysis in biological systems
J. Lipid Res.,
October 1, 2006;
47(10):
2101 - 2111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Ebrahem, K. Renganathan, J. Sears, A. Vasanji, X. Gu, L. Lu, R. G. Salomon, J. W. Crabb, and B. Anand-Apte
Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration
PNAS,
September 5, 2006;
103(36):
13480 - 13484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Moore and M. W. Freeman
Scavenger Receptors in Atherosclerosis: Beyond Lipid Uptake
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2006;
26(8):
1702 - 1711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nonas, I. Miller, K. Kawkitinarong, S. Chatchavalvanich, I. Gorshkova, V. N. Bochkov, N. Leitinger, V. Natarajan, J. G. N. Garcia, and K. G. Birukov
Oxidized Phospholipids Reduce Vascular Leak and Inflammation in Rat Model of Acute Lung Injury
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1130 - 1138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sun, S. C. Finnemann, M. Febbraio, L. Shan, S. P. Annangudi, E. A. Podrez, G. Hoppe, R. Darrow, D. T. Organisciak, R. G. Salomon, et al.
Light-induced Oxidation of Photoreceptor Outer Segment Phospholipids Generates Ligands for CD36-mediated Phagocytosis by Retinal Pigment Epithelium: A POTENTIAL MECHANISM FOR MODULATING OUTER SEGMENT PHAGOCYTOSIS UNDER OXIDANT STRESS CONDITIONS
J. Biol. Chem.,
February 17, 2006;
281(7):
4222 - 4230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, L. N. Thorne, N. M. Punjabi, C.-K. Sun, A. R. Schwartz, P. L. Smith, R. L. Marino, A. Rodriguez, W. C. Hubbard, C. P. O'Donnell, et al.
Intermittent Hypoxia Induces Hyperlipidemia in Lean Mice
Circ. Res.,
September 30, 2005;
97(7):
698 - 706.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Berliner and A. D. Watson
A Role for Oxidized Phospholipids in Atherosclerosis
N. Engl. J. Med.,
July 7, 2005;
353(1):
9 - 11.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Januszewski, N. L. Alderson, A. J. Jenkins, S. R. Thorpe, and J. W. Baynes
Chemical modification of proteins during peroxidation of phospholipids
J. Lipid Res.,
July 1, 2005;
46(7):
1440 - 1449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. I. Miller, S. Viriyakosol, D. S. Worrall, A. Boullier, S. Butler, and J. L. Witztum
Toll-Like Receptor 4-Dependent and -Independent Cytokine Secretion Induced by Minimally Oxidized Low-Density Lipoprotein in Macrophages
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2005;
25(6):
1213 - 1219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Nicholls and S. L. Hazen
Myeloperoxidase and Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2005;
25(6):
1102 - 1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Boullier, P. Friedman, R. Harkewicz, K. Hartvigsen, S. R. Green, F. Almazan, E. A. Dennis, D. Steinberg, J. L. Witztum, and O. Quehenberger
Phosphocholine as a pattern recognition ligand for CD36,
J. Lipid Res.,
May 1, 2005;
46(5):
969 - 976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Park, F. G. Adsit, and J. C. Boyington
The 1.4 A Crystal Structure of the Human Oxidized Low Density Lipoprotein Receptor Lox-1
J. Biol. Chem.,
April 8, 2005;
280(14):
13593 - 13599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Milne, J. R. Seal, C. M. Havrilla, M. Wijtmans, and N. A. Porter
Identification and analysis of products formed from phospholipids in the free radical oxidation of human low density lipoproteins
J. Lipid Res.,
February 1, 2005;
46(2):
307 - 319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Greaves and S. Gordon
Thematic review series: The Immune System and Atherogenesis. Recent insights into the biology of macrophage scavenger receptors
J. Lipid Res.,
January 1, 2005;
46(1):
11 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Srivastava, M. Spite, J. O. Trent, M. B. West, Y. Ahmed, and A. Bhatnagar
Aldose Reductase-catalyzed Reduction of Aldehyde Phospholipids
J. Biol. Chem.,
December 17, 2004;
279(51):
53395 - 53406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-K. Chang, C. J. Binder, Y. I. Miller, G. Subbanagounder, G. J. Silverman, J. A. Berliner, and J. L. Witztum
Apoptotic Cells with Oxidation-specific Epitopes Are Immunogenic and Proinflammatory
J. Exp. Med.,
December 6, 2004;
200(11):
1359 - 1370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Febbraio, E. Guy, and R. L. Silverstein
Stem Cell Transplantation Reveals That Absence of Macrophage CD36 Is Protective Against Atherosclerosis
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2004;
24(12):
2333 - 2338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kumagai, N. Matsukawa, Y. Kaneko, Y. Kusumi, M. Mitsumata, and K. Uchida
A Lipid Peroxidation-derived Inflammatory Mediator: IDENTIFICATION OF 4-HYDROXY-2-NONENAL AS A POTENTIAL INDUCER OF CYCLOOXYGENASE-2 IN MACROPHAGES
J. Biol. Chem.,
November 12, 2004;
279(46):
48389 - 48396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev,
October 1, 2004;
84(4):
1381 - 1478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Coleman Jr, R. K. Polanowska-Grabowska, M. Marcinkiewicz, and A. R. L. Gear
LDL oxidized by hypochlorous acid causes irreversible platelet aggregation when combined with low levels of ADP, thrombin, epinephrine, or macrophage-derived chemokine (CCL22)
Blood,
July 15, 2004;
104(2):
380 - 389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. POLIAKOV, M.-L. BRENNAN, J. MACPHERSON, R. ZHANG, W. SHA, L. NARINE, R. G. SALOMON, and S. L. HAZEN
Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo
FASEB J,
December 1, 2003;
17(15):
2209 - 2220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Gu, S. G. Meer, M. Miyagi, M. E. Rayborn, J. G. Hollyfield, J. W. Crabb, and R. G. Salomon
Carboxyethylpyrrole Protein Adducts and Autoantibodies, Biomarkers for Age-related Macular Degeneration
J. Biol. Chem.,
October 24, 2003;
278(43):
42027 - 42035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Culbertson, E. I. Vassilenko, L. D. Morrison, and Keith. U. Ingold
Paradoxical Impact of Antioxidants on Post-Amadori Glycoxidation: COUNTERINTUITIVE INCREASE IN THE YIELDS OF PENTOSIDINE AND N{epsilon}-CARBOXYMETHYLLYSINE USING A NOVEL MULTIFUNCTIONAL PYRIDOXAMINE DERIVATIVE
J. Biol. Chem.,
October 3, 2003;
278(40):
38384 - 38394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Itabe, M. Mori, Y. Fujimoto, Y. Higashi, and T. Takano
Minimally Modified LDL Is an Oxidized LDL Enriched with Oxidized Phosphatidylcholines
J. Biochem.,
September 1, 2003;
134(3):
459 - 465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. de Assis, A. R. Silva, L. F. C. Caiado, G. K. Marathe, G. A. Zimmerman, S. M. Prescott, T. M. McIntyre, P. T. Bozza, and H. C. de Castro-Faria-Neto
Synergism Between Platelet-Activating Factor-Like Phospholipids and Peroxisome Proliferator-Activated Receptor {gamma} Agonists Generated During Low Density Lipoprotein Oxidation That Induces Lipid Body Formation in Leukocytes
J. Immunol.,
August 15, 2003;
171(4):
2090 - 2098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. E. Kagan, G. G. Borisenko, B. F. Serinkan, Y. Y. Tyurina, V. A. Tyurin, J. Jiang, S. X. Liu, A. A. Shvedova, J. P. Fabisiak, W. Uthaisang, et al.
Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization, and recognition of phosphatidylserine
Am J Physiol Lung Cell Mol Physiol,
July 1, 2003;
285(1):
L1 - L17.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kawai, A. Saito, N. Shibata, M. Kobayashi, S. Yamada, T. Osawa, and K. Uchida
Covalent Binding of Oxidized Cholesteryl Esters to Protein: IMPLICATIONS FOR OXIDATIVE MODIFICATION OF LOW DENSITY LIPOPROTEIN AND ATHEROSCLEROSIS
J. Biol. Chem.,
May 30, 2003;
278(23):
21040 - 21049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Englyst, J. M. Taube, T. J. Aitman, T. P. Baglin, and C. D. Byrne
A Novel Role for CD36 in VLDL-Enhanced Platelet Activation
Diabetes,
May 1, 2003;
52(5):
1248 - 1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Chen, R. L. Fitzgerald, J. E. Saffitz, C. F. Semenkovich, and G. Schonfeld
Amino Terminal 38.9% of Apolipoprotein B-100 Is Sufficient to Support Cholesterol-Rich Lipoprotein Production and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2003;
23(4):
668 - 674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. F. Hoff, J. O'Neil, Z. Wu, G. Hoppe, and R. L. Salomon
Phospholipid Hydroxyalkenals: Biological and Chemical Properties of Specific Oxidized Lipids Present in Atherosclerotic Lesions
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2003;
23(2):
275 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Podrez, E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P. J. Finton, L. Shan, M. Febbraio, D. P. Hajjar, et al.
A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions
J. Biol. Chem.,
October 4, 2002;
277(41):
38517 - 38523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Hazen and G. M. Chisolm
Oxidized phosphatidylcholines: Pattern recognition ligands for multiple pathways of the innate immune response
PNAS,
October 1, 2002;
99(20):
12515 - 12517.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|